home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

The Dynamics Of A Human Cancer Revealed

  July, 12 2005 10:22
your information resource in human molecular genetics
A team of researchers has developed a mathematical model based on the biology of blood cell formation to describe how certain cancer cells respond to a molecularly targeted therapy, according to a Letter in the 30 June 2005 issue of Nature (Vol. 435, No. 7046, pp. 1267-1270).

Chronic myeloid leukaemia is caused by a genetic mutation that produces an abnormal protein that tells the body to continuously produce a type of white blood cell. Imatinib is a specific inhibitor that interferes with the activity of this protein and in many patients this drug results in the rapid decline of cancer cells. However, imatinib does not eliminate disease and a greater understanding of how the drug exerts its effect is needed.

To that end, Franziska Michor and colleagues used a mathematical approach to show that imatinib successfully reduces the number of leukaemic cells, but does not appear to eliminate leukaemic stem cells in vivo. The work also demonstrates that mutations in the target of imatinib probably occur in leukaemic stem cells, which has implications for future drug development and strategies to combat resistance.


Franziska Michor (Harvard University, Cambridge, MA, USA)
E-mail: michor@fas.harvard.edu

Gary Gilliland (Harvard Medical School, Boston, MA, USA)
E-mail: ggilliland@rics.bwh.harvard.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.